Article
Rubicon Genomics, Inc.
Pharmacogenomics - 1 Jul 2002
Langmore John P
Abstract excerpt
Rubicon Genomics, Inc. is a leader in development and application of effective methods to analyze human DNA for genome-wide genotyping and haplotyping. The company is developing its proprietary OmniPlex technology as an integrated platform for archiving, amplifying and analyzing patient DNA for drug target discovery, pharmacogenomics and diagnostics. Single-site, multiple-site or whole genome amplification can be...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
